PhRMA Jumps Into Battle Over Mifepristone Regulation With Supreme Court Filing

 
• By Brenda Sandburg

After sitting out the initial rounds, trade group backs FDA’s decisions on the medication abortion pill and asks Supreme Court to stay Texas district court ruling suspending the drug’s approval.

Court Ruling
PhRMA expresses concern about an ‘unprecedented assault on FDA’s approval decisions.’ • Source: Alamy

More from US FDA

More from Agency Leadership